InsiderClue
Insiders · Profile

Chen Bihua

Director at BlossomHill Therapeutics · Former 10% Owner at MoonLake Immunotherapeutics · CEO and Chairperson at BridgeBio Oncology Therapeutics · and 2 more. Filing since 22 Oct 2020. CIK 0001599214

BLSM BlossomHill Therapeutics, Inc. Director · 1 trade MLTX MoonLake Immunotherapeutics Former 10% Owner · 12 trades BBOT BridgeBio Oncology Therapeutics, Inc. CEO and Chairperson · 1 trade BMEA Biomea Fusion, Inc. Director · 2 trades ERAS Erasca, Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BLSM BlossomHill Therapeutics, Inc.
10 Aug 2026
Director
Bought
312,500
$5.00M
9.5%
MLTX MoonLake Immunotherapeutics
30 Sep 2025
Former 10% Owner
Sold at will
5,827
$40.56K
0.3%
MLTX MoonLake Immunotherapeutics
29 Sep 2025
Former 10% Owner
Sold at will
6,494,151
$46.83M
76.5%
BBOT BridgeBio Oncology Therapeutics, Inc.
13 Feb 2024
CEO and Chairperson
Bought
2,400,000
$24.00M
opened
MLTX MoonLake Immunotherapeutics
5 Oct 2023
10% owner
Bought
58,839
$3.52M
0.7%
MLTX MoonLake Immunotherapeutics
4 Oct 2023
10% owner
Bought
67,814
$3.89M
0.8%
MLTX MoonLake Immunotherapeutics
3 Oct 2023
10% owner
Bought
150,487
$8.62M
1.8%
MLTX MoonLake Immunotherapeutics
2 Oct 2023
10% owner
Bought
74,911
$4.30M
0.9%
MLTX MoonLake Immunotherapeutics
30 Jun 2023
10% owner
Bought
800,000
$40.00M
19.4%
MLTX MoonLake Immunotherapeutics
26 Jun 2023
10% owner
Bought
450,000
$20.54M
12.2%
BMEA Biomea Fusion, Inc.
30 Mar 2023
Director
Bought
400,000
$12.00M
12.6%
MLTX MoonLake Immunotherapeutics
21 Mar 2023
10% owner
Bought
238,511
$5.18M
6.9%
MLTX MoonLake Immunotherapeutics
20 Mar 2023
10% owner
Bought
588,589
$11.60M
20.7%
ERAS Erasca, Inc.
13 Dec 2022
Director
Bought
307,692
$2.00M
2.9%
MLTX MoonLake Immunotherapeutics
5 Apr 2022
10% owner
Bought
2,850,000
$28.50M
opened
ERAS Erasca, Inc.
10 Aug 2021
Director
Bought
200,000
$4.42M
1.9%
ERAS Erasca, Inc.
26 Jul 2021
Director
Sold, plan not stated
200,000
$3.75M
1.9%
ERAS Erasca, Inc.
20 Jul 2021
Director
Bought
950,000
$15.20M
9.9%
BMEA Biomea Fusion, Inc.
20 Apr 2021
Director
Bought
900,000
$15.30M
39.6%
MLTX MoonLake Immunotherapeutics
22 Oct 2020
CEO and Chairman
Bought
430,000
$4.30M
opened
20 decisions on file.